BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24628817)

  • 1. Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer.
    Chen X; Sun L; Cong Y; Zhang T; Lin Q; Meng Q; Pang H; Zhao Y; Li Y; Cai L; Dong X
    J Exp Clin Cancer Res; 2014 Mar; 33(1):28. PubMed ID: 24628817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications.
    Puglisi F; Follador A; Minisini AM; Cardellino GG; Russo S; Andreetta C; Di Terlizzi S; Piga A
    Ann Oncol; 2005 Feb; 16(2):263-6. PubMed ID: 15668281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile and Outcome of Supraclavicular Metastases in Patients with Metastatic Breast Cancer: Discordance of Receptor Status Between Primary and Metastatic Site.
    Thangarajah F; Vogel C; Pahmeyer C; Eichler C; Holtschmidt J; Ratiu D; Mallmann P; Malter W
    Anticancer Res; 2018 Oct; 38(10):6023-6026. PubMed ID: 30275235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Case to Case Comparison of Hormone Receptors and HER2 Status between Primary Breast Cancer and Synchronous Axillary Lymph Node Metastasis.
    Sujarittanakarn S; Himakhun W; Worasawate W; Prasert W
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1559-1565. PubMed ID: 32592349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast cancer disease characteristics: implications for tumor biology and research.
    Alqaisi A; Chen L; Romond E; Chambers M; Stevens M; Pasley G; Awasthi M; Massarweh S
    Breast Cancer Res Treat; 2014 Nov; 148(2):437-44. PubMed ID: 25257728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
    Sihto H; Lundin J; Lundin M; Lehtimäki T; Ristimäki A; Holli K; Sailas L; Kataja V; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Breast Cancer Res; 2011 Sep; 13(5):R87. PubMed ID: 21914172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different Breast Cancer Subtypes Show Different Metastatic Patterns: A Study from A Large Public Database.
    Guo Y; Arciero CA; Jiang R; Behera M; Peng L; Li X
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3587-3593. PubMed ID: 33369456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
    Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
    Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
    van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
    Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinicopathological factors associated with bone metastasis in breast cancer.
    Chen J; Zhu S; Xie XZ; Guo SF; Tong LQ; Zhou S; Zhao M; Xianyu ZQ; Zhu XH; Xiong W
    J Huazhong Univ Sci Technolog Med Sci; 2013 Feb; 33(1):122-125. PubMed ID: 23392720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of circulating tumor cells according to immunohistochemically defined molecular subtypes in advanced breast cancer.
    Munzone E; Botteri E; Sandri MT; Esposito A; Adamoli L; Zorzino L; Sciandivasci A; Cassatella MC; Rotmensz N; Aurilio G; Curigliano G; Goldhirsch A; Nolè F
    Clin Breast Cancer; 2012 Oct; 12(5):340-6. PubMed ID: 23040002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype.
    Press DJ; Miller ME; Liederbach E; Yao K; Huo D
    Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal surveillance for postoperative metastasis in breast cancer patients.
    Makita M; Sakai T; Ogiya A; Kitagawa D; Morizono H; Miyagi Y; Iijima K; Iwase T
    Breast Cancer; 2016 Mar; 23(2):286-94. PubMed ID: 25294313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of distant recurrence according to the molecular subtypes in Korean women with breast cancer.
    Park HS; Kim S; Kim K; Yoo H; Chae BJ; Bae JS; Song BJ; Jung SS
    World J Surg Oncol; 2012 Jan; 10():4. PubMed ID: 22226178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.
    Du F; Yuan P; Wang JY; Ma F; Fan Y; Luo Y; Xu BH
    Asian Pac J Cancer Prev; 2015; 16(3):903-7. PubMed ID: 25735380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of breast cancer: what standards should be used in research and clinical practice?
    Ravaioli A; Tassinari D; Pasini G; Polselli A; Papi M; Fattori PP; Pasquini E; Masi A; Alessandrini F; Canuti D; Panzini I; Drudi G
    Ann Oncol; 1998 Nov; 9(11):1173-7. PubMed ID: 9862046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.